Unknown

Dataset Information

0

Structural bases of norovirus RNA dependent RNA polymerase inhibition by novel suramin-related compounds.


ABSTRACT: Noroviruses (NV) are +ssRNA viruses responsible for severe gastroenteritis; no effective vaccines/antivirals are currently available. We previously identified Suramin (9) as a potent inhibitor of NV-RNA dependent RNA polymerase (NV-RdRp). Despite significant in vitro activities versus several pharmacological targets, Suramin clinical use is hampered by pharmacokinetics/toxicity problems. To improve Suramin access to NV-RdRp in vivo, a Suramin-derivative, 8, devoid of two sulphonate groups, was synthesized, achieving significant anti-human-NV-RdRp activity (IC50?=?28 nM); the compound inhibits also murine NV (mNV) RdRp. The synthesis process led to the isolation/characterization of lower molecular weight intermediates (3-7) hosting only one sulphonate head. The crystal structures of both hNV/mNV-RdRps in complex with 6, were analyzed, providing new knowledge on the interactions that a small fragment can establish with NV-RdRps, and establishing a platform for structure-guided optimization of potency, selectivity and drugability.

SUBMITTER: Croci R 

PROVIDER: S-EPMC3951423 | biostudies-literature | 2014

REPOSITORIES: biostudies-literature

altmetric image

Publications

Structural bases of norovirus RNA dependent RNA polymerase inhibition by novel suramin-related compounds.

Croci Romina R   Pezzullo Margherita M   Tarantino Delia D   Milani Mario M   Tsay Shwu-Chen SC   Sureshbabu Radhakrishnan R   Tsai Yi-Jin YJ   Mastrangelo Eloise E   Rohayem Jacques J   Bolognesi Martino M   Hwu Jih Ru JR  

PloS one 20140312 3


Noroviruses (NV) are +ssRNA viruses responsible for severe gastroenteritis; no effective vaccines/antivirals are currently available. We previously identified Suramin (9) as a potent inhibitor of NV-RNA dependent RNA polymerase (NV-RdRp). Despite significant in vitro activities versus several pharmacological targets, Suramin clinical use is hampered by pharmacokinetics/toxicity problems. To improve Suramin access to NV-RdRp in vivo, a Suramin-derivative, 8, devoid of two sulphonate groups, was s  ...[more]

Similar Datasets

| S-EPMC546540 | biostudies-literature
| S-EPMC9861054 | biostudies-literature
| S-EPMC3187498 | biostudies-literature
| S-EPMC6305289 | biostudies-literature
| S-EPMC2984200 | biostudies-literature
| S-EPMC7332347 | biostudies-literature
| S-EPMC1797576 | biostudies-literature
| S-EPMC7795727 | biostudies-literature
| S-EPMC516629 | biostudies-literature
| S-EPMC4948327 | biostudies-literature